Preclinical evaluation of anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4-tetrahydroquinoline
Authors
Abstract:
Anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4- tetrahydro-quinoline (NTQ), a newly synthesized ameltolide analog, was investigated with regards to efficacy and toxicity in mice. Additionally, its effect on NMDA receptors was also performed on NR1a/NR2B expressed in Xenopus oocytes. NTQ, given intraperitoneally, was able to protect the animals in both maximal electroshock seizure and pentylenetetrazole (PTZ) tests, while ameltolide was effective only in the MES. NTQ was less potent than ameltolide, exhibiting the median effective dose (ED50) of 13.33 mg/kg body weight (B.W.), whereas the corresponding value of ameltolide was 0.96 mg/kg B.W. Ameltolide seemed to possess better safety profile than NTQ as indicated by the relative safety margin (LD50/ED50) of 65.28 for ameltolide and 44.97 for NTQ. Furthermore, based on the finding that the median neurotoxic dose (TD50) established by rotarod test was 37.28 and 7.18 mg/kg B.W. for ameltolide and NTQ respectively, ameltolide appeared to have more favorable protective index (TD50/ED50) than NTQ. Further experiment using Xenopus oocyte with NMDA receptor composing of NR1a and NR2B subunits was performed to probe for the effect of NTQ and ameltolide on NMDA-induced current. While NTQ and ameltolide did not induce any changes in current or a shift in membrane potential of oocyte, both of them significantly inhibited NMDA-induced current demonstrating the IC50 of 0.10 and 0.12 ?M respectively. Therefore, it is likely that inhibition of excitation of NMDA receptor may, at least in part, accounted for its anticonvulsant activity. In conclusion, the present study has identified NTQ as a broad-spectrum anticonvulsant agent, albeit its lower safety margin and protective index. Inhibition of NMDA receptor may partly contribute to anticonvulsant activity of these two compounds. Further structural modification of NTQ to improve its safety while preserving a broad-spectrum anticonvulsant activity should be carried out.
similar resources
Evaluation of anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4-tetrahydro-4-methylquinoline
Anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4-tetrahydro-4-methylquinoline (NMQ), a newly synthesized ameltolide analogue, was investigated with regards to efficacy, lethality and neurotoxicity in mice. In vivo microdialysis experiments on freely moving rats were also performed in search for the possible effect of NMQ on cortical amino acid neurotransmitters. Similar to ameltolide, intr...
full textEvaluation of anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4-tetrahydro-4-methylquinoline
Anticonvulsant activity of N-(p-aminobenzoyl)-1,2,3,4-tetrahydro-4-methylquinoline (NMQ), a newly synthesized ameltolide analogue, was investigated with regards to efficacy, lethality and neurotoxicity in mice. In vivo microdialysis experiments on freely moving rats were also performed in search for the possible effect of NMQ on cortical amino acid neurotransmitters. Similar to ameltolide, intr...
full textcomparison of catalytic activity of heteropoly compounds in the synthesis of bis(indolyl)alkanes.
heteropoly acids (hpa) and their salts have advantages as catalysts which make them both economically and environmentally attractive, strong br?nsted acidity, exhibiting fast reversible multi-electron redox transformations under rather mild conditions, very high solubility in polar solvents, fairly high thermal stability in the solid states, and efficient oxidizing ability, so that they are imp...
15 صفحه اولSynthesis and evaluation of anticonvulsant activity of N-(2,5-dimethylphenoxy)- and N-[(2,3,5-trimethylphenoxy)alkyl]aminoalkanols.
A series of new N-(2,5-dimethylphenoxy)- and N-(2,3,5-trimethylphenoxy)alkylaminoalkanols [I-XVII] was synthesized and evaluated for anticonvulsant activity. Pharmacological tests included maximal electroshock (MES) and subcutaneous pentetrazole seizure threshold (scMet) assays as well as neurotoxicity (TOX) evaluation in mice after intraperitoneal (i.p.) administration and/or in rats after ora...
full textMy Resources
Journal title
volume Volume 3 issue Supplement 1
pages 23- 23
publication date 2010-11-20
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023